SCHEMBL14999933

SCHEMBL14999933

CCN(CC)C(=O)C(Cc1ccc(NS(C)(=O)=O)cc1)C(=O)NS(=O)(=O)c1ccc2ccccc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LARS1 Q9P2J5 1/20 0.47
ATM Q13315 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ALDH1A1 P00352 1/20 0.46
LMNA P02545 1/20 0.46
GAA P10253 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
F2 P00734 3/20 0.46
HDAC1 Q13547 2/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
PLAU P00749 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15000007 0.92 HDAC1 (0.49) LARS1ATMALDH1A1LMNAGAA
SCHEMBL13151776 0.91 LARS1 (0.48) LARS1ALDH1A1LMNAGAASMN1; SMN2
SCHEMBL18387952 0.91 LARS1 (0.48) LARS1ATMALDH1A1LMNAGAA
SCHEMBL15000288 0.91 ALDH1A1 (0.47) LARS1ATMALDH1A1LMNAGAA
SCHEMBL15000276 0.90 LARS1 (0.53) LARS1ALDH1A1LMNAF2PLG
SCHEMBL3085973 0.90 LARS1 (0.53) LARS1ALDH1A1LMNAF2PLG
SCHEMBL14999932 0.89 LARS1 (0.47) LARS1NPSR1ALDH1A1LMNAGAA
SCHEMBL3090331 0.89 LARS1 (0.47) LARS1ALDH1A1LMNAGAASMN1; SMN2
SCHEMBL18383338 0.89 LARS1 (0.50) LARS1ALDH1A1LMNAGAASMN1; SMN2
SCHEMBL13152388 0.89 LARS1 (0.50) LARS1ALDH1A1LMNAGAASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8461209-B2 Malonic acid sulfonamide derivative and pharmaceutical use thereof MITSUBISHI TANABE PHARMA CORPORATION (JP) 2013-06-11 US disclosed